EUVIMEDEUVIMED entdecken
Open Access

Dysregulated IFN-γ signals promote autoimmunity in STAT1 gain-of-function syndrome

Andrea D Largent iD, Katharina Lambert iD, Kristy Chiang iD, Natali Shumlak iD, Denny Liggitt, Mohammed Oukka, Troy R Torgerson iD, Jane H Buckner iD, Eric J Allenspach iD, David J Rawlings iD, Shaun W Jackson iD

Science Translational Medicine · 05.07.2023 · 15 (703)

DOI: 10.1126/scitranslmed.ade7028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 05.07.2023. Verfasst von Andrea D Largent und 10 weiteren Autor:innen. Beteiligte Einrichtung: Seattle Children's Research Institute, Seattle, WA 98101, USA. Hauptthemen laut MEDLINE: Autoimmunity, Gain of Function Mutation. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIAMS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterozygous signal transducer and activator of transcription 1 ( STAT1 ) gain-of-function (GOF) mutations promote a clinical syndrome of immune dysregulation characterized by recurrent infections and predisposition to humoral autoimmunity. To gain insights into immune characteristics of STAT1-driven inflammation, we performed deep immunophenotyping of pediatric patients with STAT1 GOF syndrome and age-matched controls. Affected individuals exhibited dysregulated CD4 + T cell and B cell activation, including expansion of T H 1-skewed CXCR3 + populations that correlated with serum autoantibody titers. To dissect underlying immune mechanisms, we generated Stat1 GOF transgenic mice ( Stat1 GOF mice) and confirmed the development of spontaneous humoral autoimmunity that recapitulated the human phenotype. Despite clinical resemblance to human regulatory T cell (T reg ) deficiency, Stat1 GOF mice and humans with STAT1 GOF syndrome exhibited normal T reg development and function. In contrast, STAT1 GOF autoimmunity was characterized by adaptive immune activation driven by dysregulated STAT1-dependent signals downstream of the type 1 and type 2 interferon (IFN) receptors. However, in contrast to the prevailing type 1 IFN-centric model for STAT1 GOF autoimmunity, Stat1 GOF mice lacking the type 1 IFN receptor were only partially protected from STAT1-driven systemic inflammation, whereas loss of type 2 IFN (IFN-γ) signals abrogated autoimmunity. Last, germline STAT1 GOF alleles are thought to enhance transcriptional activity by increasing total STAT1 protein, but the underlying biochemical mechanisms have not been defined. We showed that IFN-γ receptor deletion normalized total STAT1 expression across immune lineages, highlighting IFN-γ as the critical driver of feedforward STAT1 elevation in STAT1 GOF syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoimmunityGain of Function MutationHumansChildMiceAnimalsInterferon-gammaSyndromeInflammationSTAT1 Transcription Factor

Substanzen

Interferon-gammaSTAT1 Transcription FactorSTAT1 protein, human

Autor:innen und Institutionen

  • Seattle Children's Research Institute, Seattle, WA 98101, USA.
  • Benaroya Research Institute, Seattle, WA 98101, USA.
  • Department of Comparative Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.
  • Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195, USA.
  • Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195, USA.
  • Allen Institute for Immunology, Seattle, WA 98109, USA.

ORCID-Profile: Andrea D Largent, Katharina Lambert, Kristy Chiang, Natali Shumlak, Troy R Torgerson, Jane H Buckner, Eric J Allenspach, David J Rawlings, Shaun W Jackson

Förderung

  • NIAID NIH HHS
  • NIAMS NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Largent, A. D., Lambert, K., Chiang, K., Shumlak, N., Liggitt, D., Oukka, M., Torgerson, T. R., Buckner, J. H., Allenspach, E. J., Rawlings, D. J., & Jackson, S. W. (2023). Dysregulated IFN-γ signals promote autoimmunity in STAT1 gain-of-function syndrome. Science Translational Medicine, 15(703). https://doi.org/10.1126/scitranslmed.ade7028

Vancouver

Largent AD, Lambert K, Chiang K, Shumlak N, Liggitt D, Oukka M, et al. Dysregulated IFN-γ signals promote autoimmunity in STAT1 gain-of-function syndrome. Science Translational Medicine. 2023;15(703). doi:10.1126/scitranslmed.ade7028

BibTeX
@article{Largent2023,
  author = {Largent, Andrea D and Lambert, Katharina and Chiang, Kristy and Shumlak, Natali and Liggitt, Denny and Oukka, Mohammed and Torgerson, Troy R and Buckner, Jane H and Allenspach, Eric J and Rawlings, David J and Jackson, Shaun W},
  title = {Dysregulated IFN-γ signals promote autoimmunity in STAT1 gain-of-function syndrome},
  journal = {Science Translational Medicine},
  year = {2023},
  volume = {15},
  number = {703},
  doi = {10.1126/scitranslmed.ade7028}
}
Kostenlos starten →